Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
7.52
-0.19 (-2.46%)
Sep 11, 2026, 3:00 PM CST

SHA:603229 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
778.5792.76795.29816.77764.55569.7
Revenue Growth
-0.80%-0.32%-2.63%6.83%34.20%39.21%
Gross Profit
379.48404.61421.9444.36391.96308.41
Operating Income
91.98117.21184.48244.54205.2152.2
Net Income
81.06130.57206.79253.9235.38145.93
Earnings Per Share
0.100.160.250.310.290.18
EPS Growth
-56.12%-36.00%-19.36%5.84%59.45%57.55%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Raw Materials and Intermediates
754.04
Fees for Technical Services
36.83
Pharmaceutical Preparation
1.89
Total
792.76

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0041,2271,0991,124612.87674.55
Total Debt
361.53456.65272.43303.17242.02109.93
Net Cash (Debt)
642.34769.86826.1821.06370.85564.62
Net Cash Growth
-21.65%-6.81%0.61%121.40%-34.32%-19.12%
Net Cash Per Share
0.810.941.001.000.460.71

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
68.74156.51177.93221.85120.57173.9
Capital Expenditures
-96.09-104.45-111.3-163.47-271.91-310.85
Free Cash Flow
-27.3552.0666.6258.38-151.35-136.95
Free Cash Flow Growth
--21.85%14.12%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
48.74%51.04%53.05%54.40%51.27%54.14%
Operating Margin
11.82%14.79%23.20%29.94%26.84%26.72%
Pretax Margin
9.44%17.40%30.20%35.60%33.47%27.98%
Profit Margin
10.41%16.47%26.00%31.09%30.79%25.61%
FCF Margin
-3.51%6.57%8.38%7.15%-19.80%-24.04%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0640.0640.1000.0920.0570.037
Dividend Per Share Growth
-36.00%-36.00%8.58%61.30%53.91%62.72%
Dividend Yield
0.80%0.65%1.02%1.01%0.49%0.29%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
73.4962.9340.1130.8640.6471.62
Forward PE
-34.2125.9522.5834.8754.34
P/FCF Ratio
-157.82124.50134.20--
PS Ratio
7.9710.3710.439.5912.5118.35